FMP
Charles River Laboratories International, Inc.
CRL
NYSE
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.
171.04 USD
4.11 (2.4%)
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2.92B
3.54B
3.98B
4.13B
4.05B
4.41B
4.8B
5.22B
5.68B
6.18B
-
21.08
12.31
3.86
-1.92
8.83
8.83
8.83
8.83
546.58M
760.8M
619.64M
683.9M
734.58M
797.49M
867.91M
944.55M
1.03B
1.12B
18.69
21.49
15.58
16.56
18.14
18.09
18.09
18.09
18.09
-166.56M
-228.77M
-324.73M
-318.53M
-232.97M
-297.88M
-324.19M
-352.81M
-383.97M
-417.88M
-5.7
-6.46
-8.17
-7.71
-5.75
-6.76
-6.76
-6.76
-6.76
380.01M
532.03M
294.91M
365.37M
501.61M
499.61M
543.73M
591.74M
643.99M
700.86M
171.04
51.63M
4.64
1.11
2.72B
8.83B
11.55B
23.58
76.42
9.11
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2.92B
3.54B
3.98B
4.13B
4.05B
4.41B
4.8B
5.22B
5.68B
6.18B
546.58M
760.8M
619.64M
683.9M
734.58M
797.49M
867.91M
944.55M
1.03B
1.12B
-166.56M
-228.77M
-324.73M
-318.53M
-232.97M
-297.88M
-324.19M
-352.81M
-383.97M
-417.88M
380.01M
532.03M
294.91M
365.37M
501.61M
499.61M
543.73M
591.74M
643.99M
700.86M
9.11
9.11
9.11
9.11
9.11
457.91M
456.75M
455.6M
454.45M
453.3M
2.28B
9.11
721.89M
11.82B
7.65B
9.92B
2.53B
7.39B
51.63M
143.23
143.23 -0.194%